返回 
加入收藏
基于ABC-VEN矩阵分析法的某妇产医院重点监控药品分析
x
请在关注微信后，向客服人员索取文件
| 篇名： | 基于ABC-VEN矩阵分析法的某妇产医院重点监控药品分析 |
| TITLE： | |
| 摘要： | 目的：了解某妇产医院的药品使用情况，以明确需要重点监控的药品种类，为临床合理用药提供参考。方法：采用ABC分析法、关键-基本-非基本药物（VEN）分析法和ABC-VEN矩阵分析法对该院2016年1月－2017年12月门诊和住院患者使用药品品种、药品销售金额进行统计分析，以确定需重点监控的药品种类。结果：按ABC分析法将药品分为A类、B类和C类，3类药品品种数构成比分别为6.08％、7.71％、86.21％，销售金额构成比分别为70.97％、19.07％、9.96％。按VEN分析法将药品分为V类、E类和N类，3类药品品种数构成比分别为36.51％、43.61％、19.88％，销售金额构成比分别为31.89％、33.89％、34.22％。按ABC-VEN矩阵分析法将药品分为Ⅰ组（AV类、AE类、AN类、BV类、CV类）、Ⅱ组（BE类、CE类、BN类）和Ⅲ组（CN类），3组药品累计品种数构成比分别为40.56％、44.43％、15.01％，累计销售金额构成比分别为77.29％、20.52％、2.19％。N类药品中AN类以中成药、血液代用品和灌注液的销售金额构成比较高，分别为12.48％、7.92％；BN类以中成药销售金额构成比较高，为3.21％；CN类药品主要以中成药、性激素和生殖系统调节药的销售金额构成比较高，分别为1.14％、0.50％。结论：该妇产医院A类药品的销售金额占药品销售总金额的主体，应根据药品疗效进行优选；对V类和E类药品应采取积极的监管政策，纳入更多具有成本-效果优势的品种；对N类药品的管控与合理使用应重点监控，以减少不合理用药现象，特别是AN类药品中的部分中成药、血液代用品和灌注液类药品应列为重点监控品种。 |
| ABSTRACT： | OBJECTIVE：To investigate drug use in an obstetrics and gynecology hospital and confirm the types of drugs that need to be monitored so as to provide reference for rational drug use in clinic. METHODS： Activity based classification （ABC） analysis， Vital-Essential-Nonessential Medicine （VEN） analysis and ABC-VEN matrix analysis were used to statistically analyze the types of drugs in the inpatients and outpatients of this hosptial during Jan. 2016-Dec. 2017， and consumption sum in the hospital so as to determine the types of monitoring focus drugs. RESULTS： The drugs were divided into class A， B， and C by using ABC analysis， and the constitute ratio of them were 6.08％， 7.71％ and 86.21％； the constitute ratio of consumption sum were 70.97％， 19.07％ and 9.96％， respectively. The drugs were divided into class V， E and N， and the constitute ratio of them were 36.51％， 43.61％ and 19.88％； constituent ratios of their consumption sum were 31.89％， 33.89％ and 34.22％， respectively. The drugs were divided into group Ⅰ （class AV， AE， AN， BV， CV）， group Ⅱ （class BE， CE， BN） and group Ⅲ （class CN） by using ABC-VEN matrix analysis； the constitute ratios of accumulative number of drug type were 40.56％， 44.43％ and 15.01％，while those of accumulative consumption sum were 77.29％， 20.52％ and 2.19％， respectively. Among class N， the constituent ratio of consumption sum of class AN as Chinese patent medicine， blood substitutes and perfusion solutions were higher， being 12.48％ and 7.92％； that of class BN as Chinese patent medicine was higher， being 3.21％； those of class CN as Chinese patent medicine， sex hormones and modulators of the genital system were higher， being 1.14％， 0.50％. CONCLUSIONS： In the Obstetrics and Gynecology Hospital， consumption sum of class A is the main part of the total consumption sum of drugs， and they should be seleted according to therapeutic efficacy. Active regulatory policies should be adopted for class V and E so that more drug types that possess cost- effectiveness advantages； for class N， management control and reasonable utilization should be monitored closely to reduce irrational drug use. Some Chinese patent medicines， blood substitutes and perfusion solutions among class AN should be monitored and controlled emphatically. |
| 期刊： | 2019年第30卷第4期 |
| 作者： | 陈晟，胡斌，薛小荣，李琼阁，潘京京，李海燕 |
| AUTHORS： | CHEN Sheng，HU Bin，XUE Xiaorong，LI Qiongge，PAN Jingjing，LI Haiyan |
| 关键字： | ABC分析法；关键-基本-非基本药物分析法；矩阵分析法；药品使用；药品监控 |
| KEYWORDS： | ABC analysis； VEN analysis； Matrix analysis； Drug sale； Drug monitoring |
| 阅读数： | 427 次 |
| 本月下载数： | 16 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
